MD Anderson researchers named to lung and ovarian cancer Dream Teams
Approaches to cancer treatment developed by MD Anderson researchers as part of the institution’s Moon Shots Program will be, in part, the focus of two new Dream Teams announced by Stand Up to Cancer (SU2C), a national organization launched by film and media leaders to speed development of cancer treatments.
The researchers will test combinations of targeted therapy and immunotherapy against lung cancer driven by intractable KRAS...
Upon further review: Immunotherapy’s curative potential
Immunotherapy is complex, has curative potential for some patients when given alone or combined with other drugs, and needs further support...
A chance to cut off cancer's fuel supply
Think of a waterfall, and you might see why cell-signaling pathways are important to cancer research. As water cascades, it impacts everything...
New hepatitis C drugs may strain the system
The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system.
The prediction comes from a cost-effectiveness analysis led by researchers at MD Anderson. The findings, reported in the Annals of Internal Medicine, predict that the cost of providing patients their daily regimens could total $90 billion over five...
Proton therapy offers more precision, fewer side effects for head and neck cancer patients
The good news is death rates continue to decline for the most common types of cancer, including lung, colon, breast and prostate.
The...
A less-invasive route to uterine cancer diagnosis
In a study of women with high-grade uterine cancer, researchers at MD Anderson Cancer Center found sentinel lymph node (SLN) mapping accurately...
Moon Shots Program puts antibody therapies in ORBIT
A new research platform of MD Anderson’s Moon Shots Program will lead a collaboration with an international pharmaceutical company to develop...
MD Anderson immunotherapy innovator wins Paul Ehrlich and Ludwig Darmstaedter Prize
James Allison, Ph.D., chair of Immunology at MD Anderson Cancer Center, was awarded the 2015 Paul Ehrlich and Ludwig Darmstaedter Prize Saturday...
Inaugural awards benefit research, patient care in prostate cancer, cancer genomics and breast cancer
Christopher Logothetis, M.D., chair and professor of Genitourinary Medical Oncology, is the recipient of the inaugural Finneran Family Prize...